ENHANCING SHAREHOLDER VALUE THROUGH EXCEPTIONAL BUSINESS PERFORMANCE AND PRACTICES, AND THROUGH RESPONSIBLE AND EFFECTIVE COMMUNICATION WITH ITS SHAREHOLDERS.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth’s pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19 as well as one license agreement for a smart phone based COVID-19 testing device.
Keep up to date on Hoth Therapeutics News. Simply fill out your
email below and you will be added to our email newsletter.